DK1441761T3 - Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr - Google Patents

Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr

Info

Publication number
DK1441761T3
DK1441761T3 DK02806687T DK02806687T DK1441761T3 DK 1441761 T3 DK1441761 T3 DK 1441761T3 DK 02806687 T DK02806687 T DK 02806687T DK 02806687 T DK02806687 T DK 02806687T DK 1441761 T3 DK1441761 T3 DK 1441761T3
Authority
DK
Denmark
Prior art keywords
animals
preventing
methods
flavivirus infection
treating flavivirus
Prior art date
Application number
DK02806687T
Other languages
English (en)
Inventor
Juan Arroyo
Thomas P Monath
Original Assignee
Acambis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acambis Inc filed Critical Acambis Inc
Application granted granted Critical
Publication of DK1441761T3 publication Critical patent/DK1441761T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02806687T 2001-10-19 2002-10-21 Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr DK1441761T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34684501P 2001-10-19 2001-10-19
PCT/US2002/033795 WO2003063725A2 (en) 2001-10-19 2002-10-21 Methods of preventing and treating flavivirus infection in animals

Publications (1)

Publication Number Publication Date
DK1441761T3 true DK1441761T3 (da) 2007-08-27

Family

ID=27662959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02806687T DK1441761T3 (da) 2001-10-19 2002-10-21 Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr

Country Status (20)

Country Link
US (1) US6878372B2 (da)
EP (1) EP1441761B1 (da)
JP (2) JP5164305B2 (da)
KR (3) KR20120016315A (da)
AT (1) ATE359816T1 (da)
AU (1) AU2002365922B2 (da)
BR (1) BR0213408A (da)
CA (1) CA2464138C (da)
CY (1) CY1107439T1 (da)
DE (1) DE60219658T2 (da)
DK (1) DK1441761T3 (da)
ES (1) ES2284984T3 (da)
IL (2) IL161501A0 (da)
MX (1) MXPA04003692A (da)
NZ (1) NZ532385A (da)
PT (1) PT1441761E (da)
RU (1) RU2313367C2 (da)
SI (1) SI1441761T1 (da)
WO (1) WO2003063725A2 (da)
ZA (1) ZA200403047B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962708B1 (en) 1997-02-28 2005-11-08 Acambis, Inc. Chimeric flavivirus vaccines
WO2002072036A2 (en) * 2001-03-12 2002-09-19 Yale University Compositions and methods comprising west nile virus polypeptides
WO2002102828A2 (en) * 2001-06-01 2002-12-27 Acambis, Inc. Chimeric flavivirus vectors
US20050002968A1 (en) * 2002-01-15 2005-01-06 Monath Thomas P. Flavivirus vaccines
KR101194818B1 (ko) * 2002-01-15 2012-10-25 사노피 파스테르 바이오로직스, 엘엘씨 플라비바이러스 백신
ATE452900T1 (de) 2002-11-15 2010-01-15 Sanofi Pasteur Biologics Co Impfstoff gegen das west-nile-virus
EP1896069B1 (en) * 2005-06-24 2013-03-13 Intervet International BV Inactivated chimeric vaccines and related methods of use
CA2616026A1 (en) * 2005-07-22 2007-02-08 Research Development Foundation Attenuated strains of flaviviruses , and uses thereof
CA2735164C (en) * 2008-08-29 2021-08-31 Boehringer Ingelheim Vetmedica, Inc. West nile virus vaccine
WO2010085358A2 (en) * 2009-01-23 2010-07-29 The Board Of Regents Of The University Of Texas System Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof
EP2772266B1 (en) 2011-03-14 2019-07-31 Boehringer Ingelheim Animal Health USA Inc. Equine Rhinitis vaccine
KR101868554B1 (ko) 2016-10-18 2018-06-19 강원대학교산학협력단 브루셀라 어보투스 ba15 변이주 및 이를 포함하는 브루셀라병 예방용 백신 조성물
GB201716222D0 (en) * 2017-10-05 2017-11-22 Univ Leuven Kath Chimeric Flavivirus Vaccines
CN113429479B (zh) * 2018-04-04 2023-03-10 中国科学院微生物研究所 一种高灵敏度的黄热病毒人源单克隆抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184024B1 (en) * 1988-07-14 2001-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and/or growth-restricted flaviviruses
DE69231570T2 (de) 1991-09-19 2001-06-21 Us Of America Represented By D Chimäre und/oder wachstumgehemmte Flaviviren
HU228705B1 (en) 1997-02-28 2013-05-28 Univ St Louis Chimeric flavivirus vaccines
WO2001039802A1 (en) 1999-12-01 2001-06-07 Oravax, Inc. Chimeric flavivirus vaccines

Also Published As

Publication number Publication date
SI1441761T1 (sl) 2007-08-31
WO2003063725A2 (en) 2003-08-07
EP1441761A2 (en) 2004-08-04
JP5164305B2 (ja) 2013-03-21
JP2005516974A (ja) 2005-06-09
KR20040052245A (ko) 2004-06-22
NZ532385A (en) 2007-01-26
CY1107439T1 (el) 2012-12-19
ES2284984T3 (es) 2007-11-16
BR0213408A (pt) 2004-11-03
US6878372B2 (en) 2005-04-12
EP1441761B1 (en) 2007-04-18
KR101131579B1 (ko) 2012-03-30
IL161501A (en) 2010-05-17
KR20120016315A (ko) 2012-02-23
WO2003063725A3 (en) 2003-10-30
IL161501A0 (en) 2004-09-27
JP2010215647A (ja) 2010-09-30
MXPA04003692A (es) 2005-04-08
RU2313367C2 (ru) 2007-12-27
ZA200403047B (en) 2005-06-29
PT1441761E (pt) 2007-07-16
AU2002365922B2 (en) 2007-11-22
CA2464138C (en) 2013-08-13
EP1441761A4 (en) 2004-12-29
DE60219658D1 (de) 2007-05-31
KR20100092038A (ko) 2010-08-19
CA2464138A1 (en) 2003-08-07
US20030129201A1 (en) 2003-07-10
DE60219658T2 (de) 2008-01-03
RU2004115107A (ru) 2005-04-20
ATE359816T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
DK1503788T3 (da) Behandling af alpha-galactosidase A-deficiens
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
DK1323222T3 (da) Önet og fremgangsmåde til drift af et önet
NO20011964L (no) Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav
NO20041513L (no) System og fremgangsmate for hurtig dynamisk linktilpasning.
DK1746375T3 (da) Oxygendrevet forbrændingssystem og anvendelser deraf
DK1404873T3 (da) Kimæriske immunmodulatoriske forbindelser og fremgangsmåder til anvendelse deraf
DK2128246T3 (da) Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
NO20034056D0 (no) Proliferative sykdommer
MY138285A (en) Fab i inhibitors
NL1021816A1 (nl) Belichtingswerkwijze en belichtingsinrichting.
DK1441761T3 (da) Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr
DE602004006967D1 (de) Telefonkonferenzverfahren und telefonkonferenzsystem
DK1567641T3 (da) Proaerolysin indeholdende proteaseaktiveringssekvenser og fremgangsmåder til anvendelse til behandling af prostatacancer.
ATE451921T1 (de) Phenylindole zur behandlung von hiv
ATE442189T1 (de) Kombination von cytochrom-p450-abhängigen protease-inhibitoren
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
DK1461047T3 (da) Sammensætninger og fremgangsmåde til behandling af dyr
DK1381382T3 (da) Fremgangsmåder og præparater til behandling af öjensygdomme
DK1355936T3 (da) Polymerkonjugater af neublastin og fremgangsmåder til anvendelse af samme
NO20042322L (no) Kretsdelkobler, anordning og pakning
NO20033921L (no) Inhibitor av monoaminopptak
DK1385993T3 (da) Fremgangsmåde til detektering og behandling af tuberøs sclerose kompleksrelaterede lidelser